Tue. Oct 26th, 2021

NORTHBROOK, Ill.–(BUSINESS WIRE)–IDEX Corporation (NYSE: IEX) today announced its financial results for the three month period ended September 30, 2021.

Third Quarter 2021 Highlights

  • Record orders of $774.2 million up 36 percent overall and 28 percent organically compared to Q3 2020
  • Record sales of $712.0 million up 23 percent overall and 15 percent organically compared to Q3 2020
  • Reported operating margin was 22.6 percent with adjusted operating margin of 24.3 percent
  • Record reported EPS was $1.51 with record adjusted EPS of $1.63
  • Full year adjusted EPS guidance narrowed to $6.30 to $6.33 compared to prior guidance of $6.26 to $6.36

Third Quarter 2021

Orders of $774.2 million were up 36 percent compared with the prior year period (+28 percent organic, +7 percent acquisitions/divestitures and +1 percent foreign currency translation).

Sales of $712.0 million were up 23 percent compared with the prior year period (+15 percent organic, +7 percent acquisitions/divestitures and +1 percent foreign currency translation).

Gross margin of 43.8 percent was up 50 basis points compared with the prior year period primarily as a result of higher volume and price capture, partially offset by inflation and supply chain constraints. Adjusted gross margin, which excludes a $9.1 million pre-tax fair value inventory step-up charge related to the Airtech acquisition, was 45.0 percent, up 170 basis points compared with the adjusted prior year period.

Operating income of $161.2 million resulted in an operating margin of 22.6 percent, which was flat compared with the prior year period. Adjusted operating income, which primarily excluded a $9.1 million pre-tax fair value inventory step-up charge and $3.2 million of restructuring expenses and asset impairments, was $173.1 million with an adjusted operating margin of 24.3 percent, up 120 basis points compared with the adjusted prior year period.

Provision for income taxes of $35.3 million in the third quarter of 2021 resulted in an effective tax rate (ETR) of 23.4 percent, which was higher than the prior year period ETR of 14.4 percent primarily due to the finalization of tax regulations enacted in the third quarter of 2020 as well as a decrease in the excess tax benefit related to share-based compensation in the current period.

Net income attributable to IDEX was $115.7 million, which resulted in EPS attributable to IDEX of $1.51. Adjusted EPS attributable to IDEX was $1.63, an increase of 23 cents, or 16.4 percent, from the adjusted prior year period and excluded the impacts of the fair value inventory step-up charge and restructuring expenses and asset impairments discussed above, both net of related tax benefits. EBITDA of $187.5 million was 26.3 percent of sales and covered interest expense by almost 20 times. Adjusted EBITDA of $199.4 million was 28.0 percent of sales and covered interest expense by 21 times.

Cash from operations of $156.6 million was up 2 percent from the prior year period primarily due to higher earnings, partially offset by changes in working capital and was 135 percent of net income attributable to IDEX. Free cash flow of $141.7 million was up 5 percent from the prior year period and was 113 percent of adjusted net income attributable to IDEX.

IDEX teams continued to navigate a tremendously challenging supply chain environment and achieved strong operating results in the third quarter. We saw broad-based strength across our portfolio, resulting in record orders and sales of $774 million and $712 million, respectively. Today’s global challenges will increasingly drive growth towards problem solvers like IDEX, but in the short term, our focus remains on overcoming the macro constraints that inhibit customer satisfaction while staying committed to investments needed to thrive in the future.

 

 

Our 80/20 principles serve us well by providing a framework to identify how to best support our customers in a difficult environment. I want to thank all IDEX team members across the globe who have tirelessly worked through these challenges and contributed to our success.

 

 

Our price capture continues to outpace material inflation and drive sequential improvements in gross margin. Despite targeted increases in discretionary costs and continued investment in the business, we achieved solid flow through, resulting in an adjusted operating margin of 24.3 percent and a record adjusted EPS of $1.63.

 

 

The acquisitions we made in the first half of the year are performing extremely well. ABEL Pumps is fully integrated and performing above expectations. Airtech is ahead of our integration timeline and is delivering on its growth potential. Our expanded corporate strategy and development team continues to actively work our M&A funnel as we look to deploy more capital. The balance sheet remains strong, with ample capital to support organic investments in business innovations and strategic M&A.

 

 

As we look to the fourth quarter, we expect organic sales growth of 9 to 10 percent with EPS in the range of $1.55 to $1.58. This assumes similar output to our third quarter results, coupled with a step up in targeted investments and the potential for year-end logistics challenges. For the full year, we are maintaining our projection of 11 to 12 percent organic sales growth and narrowing our adjusted EPS range to $6.30 to $6.33.”

 

 

 

Eric D. Ashleman

 

Chief Executive Officer and President

Third Quarter 2021 Segment Highlights

Fluid & Metering Technologies

  • Sales of $251.3 million reflected a 14 percent increase compared to the third quarter of 2020 (+7 percent organic, +6 percent acquisitions and +1 percent foreign currency translation).
  • Operating income of $69.0 million resulted in an operating margin of 27.5 percent, which was up 100 basis points compared with the prior year period primarily due to higher volume, price capture and favorable mix, partially offset by inflation, supply chain constraints and targeted increases in discretionary spending. Adjusted operating income, which excludes $2.0 million of restructuring expenses and asset impairments, was $71.0 million with an adjusted operating margin of 28.2 percent, a 150 basis point increase compared to the prior year period.
  • EBITDA of $76.4 million resulted in an EBITDA margin of 30.4 percent. Adjusted EBITDA of $78.3 million resulted in an adjusted EBITDA margin of 31.2 percent, a 90 basis point increase compared to the prior year period.

Health & Science Technologies

  • Sales of $302.3 million reflected a 37 percent increase compared to the third quarter of 2020 (+24 percent organic, +12 percent acquisitions/divestitures and +1 percent foreign currency translation).
  • Operating income of $70.4 million resulted in an operating margin of 23.3 percent, which was up 70 basis points compared with the prior year period primarily due to higher volume, price capture and favorable mix, partially offset by inflation, supply chain constraints, targeted increases in discretionary spending and the fair value inventory step-up charge related to the Airtech acquisition. Adjusted operating income, which excludes a $9.1 million pre-tax fair value inventory step-up charge related to the Airtech acquisition and $0.6 million of restructuring expenses and asset impairments, was $80.1 million with an adjusted operating margin of 26.5 percent, a 340 basis point increase compared to the prior year period.
  • EBITDA of $85.9 million resulted in an EBITDA margin of 28.4 percent. Adjusted EBITDA of $95.7 million resulted in an adjusted EBITDA margin of 31.6 percent, a 390 basis point increase compared to the prior year period.

Fire & Safety/Diversified Products

  • Sales of $159.1 million reflected a 13 percent increase compared to the third quarter of 2020 (+12 percent organic and +1 percent foreign currency translation).
  • Operating income of $39.1 million resulted in an operating margin of 24.6 percent, which was down 170 basis points compared with the prior year period primarily as a result of inflation, supply chain constraints and targeted increases in discretionary spending. Price capture and volume leverage offsets faced stronger headwinds within the segment due to higher direct OEM exposure and higher levels of material intensity due to vertical integration. Adjusted operating income was $39.1 million with an adjusted operating margin of 24.6 percent, a 260 basis point decrease compared to the prior year period.
  • EBITDA of $42.9 million resulted in an EBITDA margin of 26.9 percent. Adjusted EBITDA of $42.8 million resulted in an adjusted EBITDA margin of 26.9 percent, a 280 basis point decrease compared to the prior year period.

Corporate Costs

Corporate costs increased to $17.3 million in the third quarter of 2021 from $14.2 million in the third quarter of 2020 primarily as a result of higher variable compensation and employee-related costs.

Non-GAAP Measures of Financial Performance

The Company prepares its public financial statements in conformity with accounting principles generally accepted in the United States of America (GAAP). The Company supplements certain GAAP financial performance metrics with non-GAAP financial performance metrics. Management believes these non-GAAP financial performance metrics provide investors with greater insight, transparency and a more comprehensive understanding of the financial information used by management in its financial and operational decision-making because certain of these adjusted metrics exclude items not reflective of ongoing operations, such as fair value inventory step-up charges, restructuring expenses and asset impairments, the loss on early debt redemption, the noncash loss related to the termination of the U.S. pension plan and the impact of the settlement for a Corporate transaction indemnity. Reconciliations of non-GAAP financial performance metrics to their most comparable GAAP financial performance metrics are defined and presented below and should not be considered a substitute for, nor superior to, the financial data prepared in accordance with GAAP. The Company does not provide forward-looking guidance for EPS on a GAAP basis because it is unable to predict certain items contained in the GAAP measure without unreasonable efforts. These items may include restructuring expenses and asset impairments, special tax items, acquisition-related transaction costs and certain other unusual adjustments. There were no adjustments to GAAP financial performance metrics other than the items noted below.

  • Organic orders and sales are calculated excluding amounts from acquired or divested businesses during the first twelve months of ownership or prior to divestiture and the impact of foreign currency translation.
  • Adjusted gross profit is calculated as gross profit plus fair value inventory step-up charges.
  • Adjusted gross margin is calculated as adjusted gross profit divided by net sales.
  • Adjusted operating income is calculated as operating income plus fair value inventory step-up charges plus restructuring expenses and asset impairments plus the impact of the settlement for a Corporate transaction indemnity.
  • Adjusted operating margin is calculated as adjusted operating income divided by net sales.
  • Adjusted net income is calculated as net income plus fair value inventory step-up charges plus restructuring expenses and asset impairments plus the impact of the settlement for a Corporate transaction indemnity plus the loss on early debt redemption plus the noncash loss related to the termination of the U.S. pension plan, net of the statutory tax expense or benefit.
  • Adjusted EPS is calculated as adjusted net income divided by the diluted weighted average shares outstanding.
  • EBITDA is calculated as net income plus interest expense plus provision for income taxes plus depreciation and amortization. We reconcile EBITDA to net income on a consolidated basis as we do not allocate consolidated interest expense or consolidated provision for income taxes to our segments.
  • EBITDA interest coverage is calculated as EBITDA divided by consolidated interest expense.
  • Adjusted EBITDA is calculated as EBITDA plus fair value inventory step-up charges plus restructuring expenses and asset impairments plus the impact of the settlement for a Corporate transaction indemnity plus the loss on early debt redemption plus the noncash loss related to the termination of the U.S. pension plan.
  • Adjusted EBITDA margin is calculated as adjusted EBITDA divided by net sales.
  • Adjusted EBITDA interest coverage is calculated as Adjusted EBITDA divided by consolidated interest expense.
  • Free cash flow is calculated as cash flow from operating activities less capital expenditures.

 

 

Table 1: Reconciliations of the Change in Net Sales to Organic Net Sales

 

Three Months Ended September 30, 2021

 

Nine Months Ended September 30, 2021

 

FMT

 

HST

 

FSDP

 

IDEX

 

FMT

 

HST

 

FSDP

 

IDEX

Change in net sales

14

%

 

37

%

 

13

%

 

23

%

 

12

%

 

25

%

 

16

%

 

18

%

– Net impact from acquisitions/divestitures

6

%

 

12

%

 

%

 

7

%

 

4

%

 

4

%

 

%

 

3

%

– Impact from foreign currency

1

%

 

1

%

 

1

%

 

1

%

 

2

%

 

3

%

 

3

%

 

3

%

Change in organic net sales

7

%

 

24

%

 

12

%

 

15

%

 

6

%

 

18

%

 

13

%

 

12

%

 

 

Table 2: Reconciliations of Reported-to-Adjusted Gross Profit and Margin (dollars in thousands)

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2021

 

2020

 

2021

 

2020

Gross profit

$

311,569

 

 

$

251,500

 

 

$

910,264

 

 

$

758,256

 

+ Fair value inventory step-up charges

9,100

 

 

 

 

11,586

 

 

4,107

 

Adjusted gross profit

$

320,669

 

 

$

251,500

 

 

$

921,850

 

 

$

762,363

 

 

 

 

 

 

 

 

 

Net sales

$

712,019

 

 

$

581,113

 

 

$

2,050,002

 

 

$

1,736,824

 

 

 

 

 

 

 

 

 

Gross margin

43.8

%

 

43.3

%

 

44.4

%

 

43.7

%

Adjusted gross margin

45.0

%

 

43.3

%

 

45.0

%

 

43.9

%

 

 

Table 3: Reconciliations of Reported-to-Adjusted Operating Income and Margin (dollars in thousands)

 

 

Three Months Ended September 30,

 

2021

 

2020

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

Reported operating income (loss)

$

69,020

 

 

$

70,374

 

 

$

39,126

 

 

$

(17,335

)

 

$

161,185

 

 

$

58,402

 

 

$

49,912

 

 

$

37,103

 

 

$

(14,204

)

 

$

131,213

 

+ Restructuring expenses and asset impairments

 

1,934

 

 

 

626

 

 

 

(55

)

 

 

699

 

 

 

3,204

 

 

 

585

 

 

 

978

 

 

 

1,249

 

 

 

105

 

 

 

2,917

 

+ Fair value inventory step-up charges

 

 

 

 

9,100

 

 

 

 

 

 

 

 

 

9,100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

+ Corporate transaction indemnity

 

 

 

 

 

 

 

 

 

 

(400

)

 

 

(400

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted operating income (loss)

$

70,954

 

 

$

80,100

 

 

$

39,071

 

 

$

(17,036

)

 

$

173,089

 

 

$

58,987

 

 

$

50,890

 

 

$

38,352

 

 

$

(14,099

)

 

$

134,130

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales (eliminations)

$

251,297

 

 

$

302,287

 

 

$

159,106

 

 

$

(671

)

 

$

712,019

 

 

$

220,747

 

 

$

220,378

 

 

$

140,896

 

 

$

(908

)

 

$

581,113

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reported operating margin

 

27.5

%

 

 

23.3

%

 

 

24.6

%

 

 

n/m

 

 

 

22.6

%

 

 

26.5

%

 

 

22.6

%

 

 

26.3

%

 

 

n/m

 

 

 

22.6

%

Adjusted operating margin

 

28.2

%

 

 

26.5

%

 

 

24.6

%

 

 

n/m

 

 

 

24.3

%

 

 

26.7

%

 

 

23.1

%

 

 

27.2

%

 

 

n/m

 

 

 

23.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended September 30,

 

2021

 

2020

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

Reported operating income (loss)

$

195,384

 

 

$

212,987

 

 

$

126,483

 

 

$

(59,866

)

 

$

474,988

 

 

$

176,111

 

 

$

150,562

 

 

$

103,977

 

 

$

(48,902

)

 

$

381,748

 

+ Restructuring expenses and asset impairments

 

4,787

 

 

 

1,693

 

 

 

161

 

 

 

1,927

 

 

 

8,568

 

 

 

2,433

 

 

 

2,162

 

 

 

1,890

 

 

 

273

 

 

 

6,758

 

+ Fair value inventory step-up charges

 

2,486

 

 

 

9,100

 

 

 

 

 

 

 

 

 

11,586

 

 

 

4,107

 

 

 

 

 

 

 

 

 

 

 

 

4,107

 

+ Corporate transaction indemnity

 

 

 

 

 

 

 

 

 

 

3,500

 

 

 

3,500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted operating income (loss)

$

202,657

 

 

$

223,780

 

 

$

126,644

 

 

$

(54,439

)

 

$

498,642

 

 

$

182,651

 

 

$

152,724

 

 

$

105,867

 

 

$

(48,629

)

 

$

392,613

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales (eliminations)

$

745,939

 

 

$

827,668

 

 

$

479,402

 

 

$

(3,007

)

 

$

2,050,002

 

 

$

666,720

 

 

$

660,105

 

 

$

412,296

 

 

$

(2,297

)

 

$

1,736,824

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reported operating margin

 

26.2

%

 

 

25.7

%

 

 

26.4

%

 

 

n/m

 

 

 

23.2

%

 

 

26.4

%

 

 

22.8

%

 

 

25.2

%

 

 

n/m

 

 

 

22.0

%

Adjusted operating margin

 

27.2

%

 

 

27.0

%

 

 

26.4

%

 

 

n/m

 

 

 

24.3

%

 

 

27.4

%

 

 

23.1

%

 

 

25.7

%

 

 

n/m

 

 

 

22.6

%

 

 

Table 4: Reconciliations of Reported-to-Adjusted Net Income and EPS (in thousands, except EPS)

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2021

 

2020

 

2021

 

2020

Reported net income attributable to IDEX

$

115,742

 

 

$

103,848

 

 

$

330,645

 

 

$

276,710

 

+ Restructuring expenses and asset impairments

3,204

 

 

2,917

 

 

8,568

 

 

6,758

 

+ Tax impact on restructuring expenses and asset impairments

(771

)

 

(703

)

 

(2,060

)

 

(1,540

)

+ Fair value inventory step-up charges

9,100

 

 

 

 

11,586

 

 

4,107

 

+ Tax impact on fair value inventory step-up charges

(1,961

)

 

 

 

(2,707

)

 

(932

)

+ Loss on early debt redemption

 

 

 

 

8,561

 

 

8,421

 

+ Tax impact on loss on early debt redemption

 

 

 

 

(1,841

)

 

(1,912

)

+ Termination of the U.S. pension plan

 

 

 

 

9,688

 

 

 

+ Tax impact on termination of the U.S. pension plan

 

 

 

 

(2,083

)

 

 

+ Corporate transaction indemnity

(400

)

 

 

 

3,500

 

 

 

+ Tax impact on Corporate transaction indemnity

85

 

 

 

 

(754

)

 

 

Adjusted net income attributable to IDEX

$

124,999

 

 

$

106,062

 

 

$

363,103

 

 

$

291,612

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2021

 

2020

 

2021

 

2020

Reported diluted EPS attributable to IDEX

$

1.51

 

 

$

1.37

 

 

$

4.33

 

 

$

3.64

 

+ Restructuring expenses and asset impairments

0.04

 

 

0.04

 

 

0.11

 

 

0.09

 

+ Tax impact on restructuring expenses and asset impairments

(0.01

)

 

(0.01

)

 

(0.03

)

 

(0.02

)

+ Fair value inventory step-up charges

0.12

 

 

 

 

0.15

 

 

0.05

 

+ Tax impact on fair value inventory step-up charges

(0.03

)

 

 

 

(0.04

)

 

(0.01

)

+ Loss on early debt redemption

 

 

 

 

0.11

 

 

0.11

 

+ Tax impact on loss on early debt redemption

 

 

 

 

(0.02

)

 

(0.02

)

+ Termination of the U.S. pension plan

 

 

 

 

0.13

 

 

 

+ Tax impact on termination of the U.S. pension plan

 

 

 

 

(0.03

)

 

 

+ Corporate transaction indemnity

 

 

 

 

0.05

 

 

 

+ Tax impact on Corporate transaction indemnity

 

 

 

 

(0.01

)

 

 

Adjusted diluted EPS attributable to IDEX

$

1.63

 

 

$

1.40

 

 

$

4.75

 

 

$

3.84

 

 

 

 

 

 

 

 

 

Diluted weighted average shares outstanding

76,452

 

 

75,960

 

 

76,408

 

 

76,119

 

 

 

Table 5: Reconciliations of EBITDA to Net Income (dollars in thousands)

 

 

Three Months Ended September 30,

 

2021

 

2020

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

Reported operating income (loss)

$

69,020

 

 

$

70,374

 

 

$

39,126

 

 

$

(17,335

)

 

$

161,185

 

 

$

58,402

 

 

$

49,912

 

 

$

37,103

 

 

$

(14,204

)

 

$

131,213

 

– Other expense (income) – net

 

384

 

 

 

(236

)

 

 

50

 

 

 

432

 

 

 

630

 

 

 

(719

)

 

 

(32

)

 

 

340

 

 

 

(293

)

 

 

(704

)

+ Depreciation and amortization

 

7,737

 

 

 

15,335

 

 

 

3,787

 

 

 

110

 

 

 

26,969

 

 

 

7,163

 

 

 

10,230

 

 

 

3,854

 

 

 

104

 

 

 

21,351

 

EBITDA

 

76,373

 

 

 

85,945

 

 

 

42,863

 

 

 

(17,657

)

 

 

187,524

 

 

 

66,284

 

 

 

60,174

 

 

 

40,617

 

 

 

(13,807

)

 

 

153,268

 

– Interest expense

 

 

 

 

 

 

 

 

 

9,498

 

 

 

 

 

 

 

 

 

 

 

10,642

 

– Provision for income taxes

 

 

 

 

 

 

 

 

 

35,343

 

 

 

 

 

 

 

 

 

 

 

17,427

 

– Depreciation and amortization

 

 

 

 

 

 

 

 

 

26,969

 

 

 

 

 

 

 

 

 

 

 

21,351

 

Reported net income

 

 

 

 

 

 

 

 

$

115,714

 

 

 

 

 

 

 

 

 

 

$

103,848

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales (eliminations)

$

251,297

 

 

$

302,287

 

 

$

159,106

 

 

$

(671

)

 

$

712,019

 

 

$

220,747

 

 

$

220,378

 

 

$

140,896

 

 

$

(908

)

 

$

581,113

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reported operating margin

 

27.5

%

 

 

23.3

%

 

 

24.6

%

 

 

n/m

 

 

 

22.6

%

 

 

26.5

%

 

 

22.6

%

 

 

26.3

%

 

 

n/m

 

 

 

22.6

%

EBITDA margin

 

30.4

%

 

 

28.4

%

 

 

26.9

%

 

 

n/m

 

 

 

26.3

%

 

 

30.0

%

 

 

27.3

%

 

 

28.8

%

 

 

n/m

 

 

 

26.4

%

EBITDA interest coverage

 

 

 

 

 

 

 

 

 

19.7

 

 

 

 

 

 

 

 

 

 

 

14.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended September 30,

 

2021

 

2020

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

Reported operating income (loss)

$

195,384

 

 

$

212,987

 

 

$

126,483

 

 

$

(59,866

)

 

$

474,988

 

 

$

176,111

 

 

$

150,562

 

 

$

103,977

 

 

$

(48,902

)

 

$

381,748

 

– Other expense (income) – net

 

5,968

 

 

 

(290

)

 

 

1,833

 

 

 

9,446

 

 

 

16,957

 

 

 

(35

)

 

 

(91

)

 

 

148

 

 

 

7,299

 

 

 

7,321

 

+ Depreciation and amortization

 

22,743

 

 

 

38,382

 

 

 

11,510

 

 

 

327

 

 

 

72,962

 

 

 

19,370

 

 

 

30,806

 

 

 

11,409

 

 

 

389

 

 

 

61,974

 

EBITDA

 

212,159

 

 

 

251,659

 

 

 

136,160

 

 

 

(68,985

)

 

 

530,993

 

 

 

195,516

 

 

 

181,459

 

 

 

115,238

 

 

 

(55,812

)

 

 

436,401

 

– Interest expense

 

 

 

 

 

 

 

 

 

31,479

 

 

 

 

 

 

 

 

 

 

 

33,958

 

– Provision for income taxes

 

 

 

 

 

 

 

 

 

95,987

 

 

 

 

 

 

 

 

 

 

 

63,759

 

– Depreciation and amortization

 

 

 

 

 

 

 

 

 

72,962

 

 

 

 

 

 

 

 

 

 

 

61,974

 

Reported net income

 

 

 

 

 

 

 

 

$

330,565

 

 

 

 

 

 

 

 

 

 

$

276,710

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales (eliminations)

$

745,939

 

 

$

827,668

 

 

$

479,402

 

 

$

(3,007

)

 

$

2,050,002

 

 

$

666,720

 

 

$

660,105

 

 

$

412,296

 

 

$

(2,297

)

 

$

1,736,824

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reported operating margin

 

26.2

%

 

 

25.7

%

 

 

26.4

%

 

 

n/m

 

 

 

23.2

%

 

 

26.4

%

 

 

22.8

%

 

 

25.2

%

 

 

n/m

 

 

 

22.0

%

EBITDA margin

 

28.4

%

 

 

30.4

%

 

 

28.4

%

 

 

n/m

 

 

 

25.9

%

 

 

29.3

%

 

 

27.5

%

 

 

28.0

%

 

 

n/m

 

 

 

25.1

%

EBITDA interest coverage

 

 

 

 

 

 

 

 

 

16.9

 

 

 

 

 

 

 

 

 

 

 

12.9

 

 

 

Table 6 : Reconciliations of EBITDA to Adjusted EBITDA (dollars in thousands)

 

 

Three Months Ended September 30,

 

2021

 

2020

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

EBITDA(1)

$

76,373

 

 

$

85,945

 

 

$

42,863

 

 

$

(17,657

)

 

$

187,524

 

 

$

66,284

 

 

$

60,174

 

 

$

40,617

 

 

$

(13,807

)

 

$

153,268

 

+ Restructuring expenses and asset impairments

 

1,934

 

 

 

626

 

 

 

(55

)

 

 

699

 

 

 

3,204

 

 

 

585

 

 

 

978

 

 

 

1,249

 

 

 

105

 

 

 

2,917

 

+ Fair value inventory step-up charges

 

 

 

 

9,100

 

 

 

 

 

 

 

 

 

9,100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

+ Corporate transaction indemnity

 

 

 

 

 

 

 

 

 

 

(400

)

 

 

(400

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

$

78,307

 

 

$

95,671

 

 

$

42,808

 

 

$

(17,358

)

 

$

199,428

 

 

$

66,869

 

 

$

61,152

 

 

$

41,866

 

 

$

(13,702

)

 

$

156,185

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA margin

 

31.2

%

 

 

31.6

%

 

 

26.9

%

 

 

n/m

 

 

 

28.0

%

 

 

30.3

%

 

 

27.7

%

 

 

29.7

%

 

 

n/m

 

 

 

26.9

%

Adjusted EBITDA interest coverage

 

 

 

 

 

 

 

 

 

21.0

 

 

 

 

 

 

 

 

 

 

 

14.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended September 30,

 

2021

 

2020

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

EBITDA(1)

$

212,159

 

 

$

251,659

 

 

$

136,160

 

 

$

(68,985

)

 

$

530,993

 

 

$

195,516

 

 

$

181,459

 

 

$

115,238

 

 

$

(55,812

)

 

$

436,401

 

+ Restructuring expenses and asset impairments

 

4,787

 

 

 

1,693

 

 

 

161

 

 

 

1,927

 

 

 

8,568

 

 

 

2,433

 

 

 

2,162

 

 

 

1,890

 

 

 

273

 

 

 

6,758

 

+ Fair value inventory step-up charges

 

2,486

 

 

 

9,100

 

 

 

 

 

 

 

 

 

11,586

 

 

 

4,107

 

 

 

 

 

 

 

 

 

 

 

 

4,107

 

+ Loss on early debt redemption

 

 

 

 

 

 

 

 

 

 

8,561

 

 

 

8,561

 

 

 

 

 

 

 

 

 

 

 

 

8,421

 

 

 

8,421

 

+ Termination of the U.S. pension plan

 

6,293

 

 

 

 

 

 

1,782

 

 

 

1,613

 

 

 

9,688

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

+ Corporate transaction indemnity

 

 

 

 

 

 

 

 

 

 

3,500

 

 

 

3,500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

$

225,725

 

 

$

262,452

 

 

$

138,103

 

 

$

(53,384

)

 

$

572,896

 

 

$

202,056

 

 

$

183,621

 

 

$

117,128

 

 

$

(47,118

)

 

$

455,687

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA margin

 

30.3

%

 

 

31.7

%

 

 

28.8

%

 

 

n/m

 

 

 

27.9

%

 

 

30.3

%

 

 

27.8

%

 

 

28.4

%

 

 

n/m

 

 

 

26.2

%

Adjusted EBITDA interest coverage

 

 

 

 

 

 

 

 

 

18.2

 

 

 

 

 

 

 

 

 

 

 

13.4

 

(1) EBITDA, a non-GAAP financial measure, is reconciled to net income, its most directly comparable GAAP financial measure, immediately above in Table 5.

 

 

Table 7: Reconciliations of Cash Flows from Operating Activities to Free Cash Flow (in thousands)

 

Three Months Ended

 

Nine Months Ended

 

September 30,

 

June 30,

 

September 30,

 

2021

 

2020

 

2021

 

2021

 

2020

 

Cash flows from operating activities

$

156,633

 

 

$

153,686

 

 

$

136,272

 

 

$

402,229

 

 

$

407,899

 

– Capital expenditures

14,894

 

 

18,353

 

 

15,984

 

 

45,487

 

 

39,438

 

Free cash flow

$

141,739

 

 

$

135,333

 

 

$

120,288

 

 

$

356,742

 

 

$

368,461

 

Conference Call to be Broadcast over the Internet

IDEX will broadcast its third quarter earnings conference call over the Internet on Wednesday, October 27, 2021 at 9:30 a.

Contacts

Investor Contact:
William K. Grogan

Senior Vice President and Chief Financial Officer

(847) 498-7070

Read full story here This is a syndicated feed and is brought to you in partnership with Business Wire. Swasth Samachar and Trade News Network are not responsible for any claims made in this story.

Leave a Reply

Your email address will not be published. Required fields are marked *

Translate »